Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis
Study sponsor: Edesa Biotech Inc. · EDSA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-09-21Actual
Enrollment · participants211Actual
Source updated2024-11-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.